The Visceral Pain Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Visceral Pain Market:
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

According to The Business Research Company’s Visceral Pain Global Market Report 2024, The visceral pain treatment market size is expected to see strong growth in the next few years. It will grow to $17.70 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%.  The growth in the forecast period can be attributed to technological innovations in pain management, growing demand for non-invasive treatment options, emerging markets and untapped opportunities, personalized medicine approaches, integration of digital health solutions. Major trends in the forecast period include shift towards multimodal pain management, increasing emphasis on alternative therapies, rise of targeted therapies for specific pain types, growing role of telemedicine in pain management, integration of artificial intelligence in pain assessment.

The rising demand for analgesics is expected to fuel the growth of the visceral pain market going forward. Analgesics refer to medications that alleviate pain by diminishing or blocking the perception of pain signals in the brain. Analgesics help manage visceral pain by targeting the nervous system and modulating pain signals originating from internal organs. For instance, in December 2023, according to the Centers for Disease Control and Prevention (CDC), a US-based, science-based, data-driven organization that protects public health in the United States, meticulously documented, a total number of dispensed Buprenorphine (an opioid analgesic) prescriptions saw a notable increase from 16,011,239 in 2020 to 16,105,318 in 2021, which represents a notable 0.59% increase when contrasted with the corresponding period in 2020. Therefore, the rising demand for analgesics is driving the growth of the visceral pain market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

The visceral pain market covered in this report is segmented –

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes

2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications

3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

 Top Major Players:
Walgreens Boots Alliance Inc
Pfizer Inc.
Johnson & Johnson Services Inc.
F. Hoffmann-La Roche Ltd
Merck & Co.Inc

North America was the largest region in the visceral pain market in 2023.

Major companies operating in the visceral pain market are developing innovative products, such as NHE3 Inhibitor, to provide reliable services to customers. NHE3 inhibitors are a class of medicines that work by inhibiting the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For instance, in April 2022, Ardelyx, a US-based biopharmaceutical company, launched an NHE3 Inhibitor drug, IBSRELA. IBSRELA represents a pioneering treatment for adults with irritable bowel syndrome with constipation (IBS-C), and it works by inhibiting the Sodium-Hydrogen Exchanger 3 (NHE3) in the small intestine and colon. It has been shown to reduce abdominal pain by decreasing visceral hypersensitivity and intestinal permeability in animal studies.

 The visceral pain market report table of contents includes:

1. Executive Summary
2. Visceral Pain Market Characteristics
3. Visceral Pain Market Trends And Strategies
4. Visceral Pain Market - Macro Economic Scenario
5. Global Visceral Pain Market Size and Growth
….
32. Global Visceral Pain Market Competitive Benchmarking
33. Global Visceral Pain Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Visceral Pain Market
35.Visceral Pain Market Future Outlook and Potential Analysis
36.Appendix

 Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model